Holen Sie sich die Stockscreener-App
7.85
6.08%
0.45
Handel nachbörslich:
8.09
0.24
+3.06%
Schlusskurs vom Vortag:
$7.40
Offen:
$8.2
24-Stunden-Volumen:
47,564
Relative Volume:
5.46
Marktkapitalisierung:
$376.35M
Einnahmen:
$27,600
Nettoeinkommen (Verlust:
$-36.04M
KGV:
-9.8519
EPS:
-0.7968
Netto-Cashflow:
$-1.66M
1W Leistung:
+13.77%
1M Leistung:
+51.83%
6M Leistung:
+88.79%
1J Leistung:
+63.20%
1-Tages-Spanne:
$7.72
$8.47
1-Wochen-Bereich:
$6.97
$8.47
52-Wochen-Spanne:
$2.76
$8.47
Nanobiotix Adr Stock (NBTX) Company Profile
Vergleichen Sie NBTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
7.85 | 354.62M | 27,600 | -36.04M | -1.66M | -0.7968 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-28 | Eingeleitet | Guggenheim | Buy |
| 2023-12-08 | Eingeleitet | Leerink Partners | Outperform |
| 2021-01-06 | Eingeleitet | Evercore ISI | Outperform |
Nanobiotix Adr Aktie (NBTX) Neueste Nachrichten
Nanobiotix (NASDAQ:NBTX) Stock Price Up 2.9% – Should You Buy? - Defense World
Guggenheim Reaffirms Their Buy Rating on Nanobiotix (NBTX) - The Globe and Mail
Nanobiotix (NASDAQ:NBTX) Stock Price Down 2.5% – Should You Sell? - Defense World
Nanobiotix announces regulatory harmonization, new patent for JNJ-1900 - TipRanks
Nanobiotix Sa ADR Reports Q1 2025 Progress - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Nanobiotix présente les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) dans le cancer du pancréas et organise une conférence téléphonique et webcast - GlobeNewswire Inc.
Guggenheim cuts Nanobiotix stock target to $8, maintains buy - Investing.com
Nanobiotix SA ADR Reports 2024 Financial Results - TipRanks
Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study - Nasdaq
Mexico Chitosan Market Size & Outlook, 2022-2030 - Grand View Research
Latin America Chitosan Market Size & Outlook, 2022-2030 - Grand View Research
Middle East & Africa Chitosan Market Size & Outlook, 2030 - Grand View Research
The United States Chitosan Market Size & Outlook, 2030 - Grand View Research
Japan Chitosan Market Size & Outlook, 2022-2030 - Grand View Research
Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study - TipRanks
Nanobiotix (NBTX) Stock Soared 107.9% on a Global Pharma Deal - AskTraders.com
NBTX News Today | Why did Nanobiotix stock go down today? - MarketBeat
Nanobiotix (NBTX) Stock Price, News & Analysis - MarketBeat
Finanzdaten der Nanobiotix Adr-Aktie (NBTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):